cpl207280
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 27, 2020 (NCT04622111)
Timeline
Indications
Mechanism of action
- Free fatty acid receptor 1AGONIST
FFAR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05248776 | Phase 2 | Jan 21, 2022 | Celon Pharma SA, Government of Poland |
| NCT04622111 | Phase 1 | May 27, 2020 | Celon Pharma SA, Government of Poland |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celon Pharma SA | For profit | 2 | 2 | 2 | 2020 |
| Government of Poland | Government | 2 | 0 | 2 | 2020 |
2 organizations
Page 1 / 1